Literature DB >> 33558587

Sex-dependent alterations in behavior, drug responses and dopamine transporter expression in heterozygous DAT-Cre mice.

Kauê Machado Costa1,2, Daniela Schenkel3, Jochen Roeper4.   

Abstract

Heterozygous mice that express Cre-recombinase under the dopamine transporter promoter (DAT-Cre knock in mice, or KI) are widely used for targeting midbrain dopamine neurons, under the assumption that their constitutive physiology is not affected. We report here that these mice display striking sex-dependent behavioral and molecular differences in relation to wildtypes (WT). Male and female KI mice were constitutively hyperactive, and male KI mice showed attenuated hyperlocomotor responses to amphetamine. In contrast, female KIs displayed a marked reduction in locomotion ("calming" effect) in response to the same dose of amphetamine. Furthermore, male and female DAT-Cre KI mice showed opposing differences in reinforcement learning, with females showing faster conditioning and males showing slower extinction. Other behavioral variables, including working memory and novelty preference, were not changed compared to WT. These effects were paralleled by differences in striatal DAT expression that disproportionately affected female KI mice. Our findings reveal clear limitations of the DAT-Cre line that must be considered when using this model.

Entities:  

Year:  2021        PMID: 33558587     DOI: 10.1038/s41598-021-82600-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  69 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 3.  Using conditional mutagenesis to study the brain.

Authors:  Alexei Morozov; Christoph Kellendonk; Eleanor Simpson; Francois Tronche
Journal:  Biol Psychiatry       Date:  2003-12-01       Impact factor: 13.382

4.  Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse.

Authors:  Aristomenis Thanos; Yuki Morizane; Yusuke Murakami; Andrea Giani; Dimosthenis Mantopoulos; Maki Kayama; Mi In Roh; Norman Michaud; Basil Pawlyk; Michael Sandberg; Lucy H Young; Joan W Miller; Demetrios G Vavvas
Journal:  Am J Pathol       Date:  2012-03-17       Impact factor: 4.307

Review 5.  Inducible gene targeting in mice using the Cre/lox system.

Authors:  B Sauer
Journal:  Methods       Date:  1998-04       Impact factor: 3.608

6.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

Authors:  B Sauer; N Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 7.  Utility of genetically modified mice for understanding the neurobiology of substance use disorders.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

8.  Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons.

Authors:  Stephan Lammel; Elizabeth E Steinberg; Csaba Földy; Nicholas R Wall; Kevin Beier; Liqun Luo; Robert C Malenka
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

Review 9.  Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.

Authors:  Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Pharmacol Ther       Date:  2007-01-10       Impact factor: 12.310

10.  Gfi1Cre mice have early onset progressive hearing loss and induce recombination in numerous inner ear non-hair cells.

Authors:  Maggie Matern; Sarath Vijayakumar; Zachary Margulies; Beatrice Milon; Yang Song; Ran Elkon; Xiaoyu Zhang; Sherri M Jones; Ronna Hertzano
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

View more
  2 in total

1.  Generation of a DAT-P2A-Flpo mouse line for intersectional genetic targeting of dopamine neuron subpopulations.

Authors:  Daniel J Kramer; Erin E Aisenberg; Polina Kosillo; Drew Friedmann; David A Stafford; Angus Yiu-Fai Lee; Liqun Luo; Dirk Hockemeyer; John Ngai; Helen S Bateup
Journal:  Cell Rep       Date:  2021-05-11       Impact factor: 9.423

2.  Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior.

Authors:  Jeremy Veenstra-VanderWeele; Susanne E Ahmari; Muhammad O Chohan; Jared M Kopelman; Hannah Yueh; Zeinab Fazlali; Natasha Greene; Alexander Z Harris; Peter D Balsam; E David Leonardo; Edgar R Kramer
Journal:  Mol Psychiatry       Date:  2022-01-20       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.